Bionic pancreas simplifies type 1 diabetes management
14 November, 2022Compared to other available artificial pancreas technologies, the bionic pancreas is designed to require less user input and provides more automation.
DNA nanotransporters optimise drug delivery
09 November, 2022Researchers have designed a new class of drug transporters made of DNA that are 20,000 times smaller than a human hair and could improve how diseases are treated.
Drug found to reduce sleep apnoea severity
09 November, 2022A drug previously used to treat depression has been found to reduce obstructive sleep apnoea severity.
Breakthrough for drug delivery through blood–brain barrier
28 October, 2022In a major advance for the treatment of Alzheimer's, Australian scientists have successfully delivered drugs through patient cell models of the human blood–brain barrier.
Brain cancer drug candidate fast-tracked in clinical trials
10 October, 2022An experimental drug for advanced solid tumours, including aggressive glioblastoma, has passed the first phase of clinical trials with flying colours.
Five-year project to develop next-gen TB vaccines
10 October, 2022The Centenary Institute and the University of Sydney have been awarded a $19m contract to develop the next generation of tuberculosis vaccines.
TGA approves Pfizer vaccine in under-fives
30 September, 2022The TGA has provisionally approved Pfizer's COVID-19 vaccine for children aged six months and over, and as a booster dose in children five years and over.
Vaxxas to scale up its vaccine skin patch facility
28 September, 2022Biotech company Vaxxas will receive $8.2m from the Modern Manufacturing Initiative to support the scale-up of its potentially game-changing technology.
New ways to beat chronic pain
09 September, 2022A new study points to possible treatments for chronic pain with a surprising link to lung cancer.
3D bioprinting and AI help treat diabetes feet, osteoarthritis
08 September, 2022ROKIT's AI solution recognises the affected area of the patient, using computer vision and deep-learning technology, and then outputs a patch to a 3D printer.
TGA approves Moderna's Omicron-containing booster dose
01 September, 2022This is the first bivalent COVID-19 vaccine approved for use in Australia, triggering an immune response against the original SARS-CoV-2 virus and the BA.1 Omicron variant.
CHO cells: a staple of recombinant antibody production
25 August, 2022Recombinant antibody expert Desmond Schofield reveals the astonishing abilities of CHO cells and some of their most interesting characteristics.
New biosynthesis method for producing antibiotics
23 August, 2022Researchers fluorinated a natural antibiotic via targeted bioengineering — a method through which an entire substance class of medically relevant natural products can be modified.
Epidural nerve block helps treat psoriasis
22 August, 2022A proof-of-concept pilot study highlights the potential for epidural lidocaine injection as an effective and safe therapeutic strategy for psoriasis treatment.
Moderna to build mRNA manufacturing plant at Monash
16 August, 2022The state-of-the-art facility, which is expected to produce up to 100 million mRNA respiratory vaccine doses annually, will be located at Monash's campus in Clayton.